Brought to you by 
Start-up Orexigen Therapeutics raises $96.6mm in IPO
01 Jun 2007
Executive Summary
Orexigen Therapeutics (CNS-active combination medicines) has grossed $96.6mm in its initial public offering of 8.05mm common shares (including the overallotment) at $12 apiece. The company filed for the IPO in December 2006 and in early April 2007 had planned to sell 6mm shares between $11-13 each.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Start-up Orexigen Therapeutics raises $96.6mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice